Brooks Steriscience Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 11-07-2024
- Paid Up Capital ₹ 2.24 M
as on 11-07-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 88.39 Cr
as on 11-07-2024
- Revenue 7245197.64%
(FY 2022)
- Profit -427.67%
(FY 2022)
- Ebitda -3290.17%
(FY 2022)
- Net Worth 673.24%
(FY 2022)
- Total Assets 107.85%
(FY 2022)
About Brooks Steriscience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.24 M.
The company currently has active open charges totaling ₹88.39 Cr.
Chamarahalli Iyer, Santosh Khare, and Atul Ranchal serve as directors at the Company.
- CIN/LLPIN
U24297GJ2020PLC116152
- Company No.
116152
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Sep 2020
- Date of AGM
14 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Brooks Steriscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chamarahalli Iyer  | Director | 29-May-2023 | Current |
| Atul Ranchal | Additional Director | 22-Sep-2023 | Current |
| Santosh Khare | Whole-Time Director | 21-Oct-2021 | Current |
Financial Performance of Brooks Steriscience.
Brooks Steriscience Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 7245197.64% increase. The company also saw a substantial fall in profitability, with a 427.67% decrease in profit. The company's net worth Soared by an impressive increase of 673.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brooks Steriscience?
In 2021, Brooks Steriscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Aug 2023 | ₹65.00 Cr | Open |
Indian Bank Creation Date: 25 Mar 2021 | ₹4.00 Cr | Open |
Indian Bank Creation Date: 25 Mar 2021 | ₹8.53 Cr | Open |
How Many Employees Work at Brooks Steriscience?
Brooks Steriscience has a workforce of 174 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brooks Steriscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brooks Steriscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
